As the May issues of Human Reproduction and Fertility and Sterility hit our desks this morning, the conversation has shifted toward the “Truth in Data.” We are no longer debating whether AI can see; we are debating what constitutes its “Ground Truth.”
Today’s Science for Smile explores a seminal contribution from the May 2026 issue of Human Reproduction that challenges our reliance on traditional diagnostic gold standards.
The Clinical Question
How does the selection of “Ground Truth”, whether based on human consensus, surgical outcomes, or live birth data, impact the reliability and clinical utility of AI models in reproductive medicine?
The Mechanism: Closing the “Truth Gap”
AI models are typically trained on labelled datasets provided by human experts (e.g., “This is a 4AA blastocyst”). However, human experts often disagree, creating a “Truth Gap.”
This week’s research introduces Latent Class Modelling, a method that allows AI to learn from the underlying patterns of successful outcomes (like live births) rather than just mimicking human labels. By identifying Non-Linear Morphokinetic Signatures (NLMS) that correlate with healthy offspring but are often overlooked by manual grading, the AI creates its own objective “Ground Truth” that surpasses the accuracy of its human trainers.
Evidence Summary
In the May 2026 issue of Human Reproduction, a pivotal analysis by Deslandes et al. (“The problem with the ‘truth’: rethinking ground truth for AI”) highlights that while AI is often benchmarked against human consensus, this consensus is inherently subjective.
Parallel data from Fertility and Sterility suggest that AI models utilising objective outcome data are achieving significant clinical leaps:
• 10% to 25% higher accuracy in predicting embryo viability compared to traditional morphological assessment.
• 30% to 50% reduction in embryologist workload, allowing senior staff to focus on complex interventions while the AI handles high-volume ranking.
The AI Workflow
1. Data De-biasing: The AI is fed raw, unlabeled time-lapse sequences paired only with final clinical outcomes (e.g., Live Birth vs. No Pregnancy).
2. Unsupervised Feature Discovery: Using a Deep Learning architecture, the model identifies kinetic milestones (like the exact timing of t2 to t5) that statistically correlate with success.
3. Ground Truth Recalibration: The model ignores human-assigned grades (like ‘4BB’) if the kinetic data suggests high implantation potential.
4. Clinical Ranking: The system provides a “Success Probability Index” (0–1.0) that acts as an independent, data-driven second opinion for the transfer order.
Limitations & Bias
The primary risk here is “Overfitting to the Outcome.” If a model is trained exclusively on “Live Birth,” it may miss embryos that were perfectly viable but failed due to uterine factors or poor endometrial receptivity.
Furthermore, as Popovic et al. note in their May 2026 mini-review, “Navigating uncertainty in PGT-A,” we must still align these analytical AI scores with biological and clinical evidence. This is crucial to avoid “The Dealership of Medicine”, where we sell add-ons based on hype rather than evidence-based necessity.
Practice Takeaway
Trust the Data, but Verify the Source.
When evaluating new AI or FertiTech tools for your clinic, you must ask: “What was the Ground Truth used for training?”
• If the model were only trained to mimic human grades, it would only be as good as your best embryologist.
• If it were trained on Live Birth Outcomes, it would offer a genuine diagnostic advantage.
Next Step: Start integrating these outcome-trained models as “Decision Support” in your weekly case reviews to reduce subjectivity in your Single Embryo Transfer (SET) protocols.
References
1. Deslandes, A., et al. (2026). The problem with the ‘truth’: rethinking ground truth for artificial intelligence in endometriosis and embryo diagnosis. Human Reproduction, 41(5), 650–657.
2. Popovic, M., et al. (2026). Navigating uncertainty in PGT-A: aligning analytical, biological, and clinical evidence. Human Reproduction, 41(5), 665–676.
3. Artificial Intelligence in Routine IVF Practice: A Roadmap for Responsible Adoption. PMC / NIH, May 2026.
For Clinicians: Stay at the forefront of reproductive science. Join our digital health collaborative to access real-time AI-driven benchmarks and advanced dose-prediction tools.
👉 Contact our Clinical Relations Team
https://www.google.com/search?q=https://santaan.in/contact-us
Technical Metadata